Abstract
SJ Szelfer, C Vogelberg, JA Bernstein. J Allergy Clin Immunol Pract. 2019;7(7):2286–95.e4 Exploratory analysis to determine whether treatment with tiotropium added to inhaled corticosteroids (ICS) is effective in children and adolescents regardless of T2 status and phenotype. Approximately 1500 children with symptomatic moderate or severe asthma ages 6–17 years who had participated in 4 Phase III randomized, double-blind, placebo controlled parallel group trials. Only a minority of patients with moderate asthma were on long-acting bronchodilator (LABA), but the majority of those with …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
